Future Science Group
Browse
fon-2019-0141 Infographic.pdf (1.15 MB)

Infographic – Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design

Download (1.15 MB)
figure
posted on 2022-06-29, 08:47 authored by Taylor & FrancisTaylor & Francis, Daniel VT Catenacci, Anteneh Tesfaye, Mohamed Tejani, Eric Cheung, Peter Eisenberg, Aaron J Scott, Clarence Eng, James Hnatyszyn, Neyssa Marina, Janine Powers, Zev Wainberg

 Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design 

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC